6ML vs ADCT: Side-by-Side Comparison
Compare MOLECULAR PARTNERS SF 1 (6ML) and Adc Therapeutics SA (ADCT) side by side: market cap EUR 126.79M vs USD 151.36M. Financials, growth and model signals on Bullrun.
| Metric | 6ML | ADCT |
|---|---|---|
| Company | MOLECULAR PARTNERS SF 1 | Adc Therapeutics SA |
| Country / Exchange | Switzerland · F | Switzerland · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers-Specialty & Generic |
| Market cap | EUR 126.79M | USD 151.36M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | — | USD 81.36M |
| Revenue growth YoY | — | +14.9% |
| Net income | — | USD -142.60M |
| Gross margin | — | 92.9% |
| Diluted EPS | — | -1.12 |